Skip to content

Supplier News

Perrigo purchases ScarAway brand

Perrigo purchases ScarAway brand

Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.

Aurobindo cleared to market Baraclude generic

Aurobindo cleared to market Baraclude generic

Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.

Alvogen to acquire four products from Pfizer

Alvogen to acquire four products from Pfizer

Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine.

Heartland to buy Splenda brand from J&J

Heartland to buy Splenda brand from J&J

Heartland Food Products Group plans to acquire the Splenda low-calorie sweetener brand from McNeil Nutritionals LLC, a subsidiary of Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Heartland said the transaction is slated to close before the end of this year.

Upsher-Smith promotes Field to president

Upsher-Smith promotes Field to president

Rusty Field, chief commercial officer at Upsher-Smith Laboratories Inc., has been appointed as president of the company. Upsher-Smith said Monday that in the new role, Field will be responsible for delivering revenue and profitability to meet the pharmaceutical company’s growth objectives.